Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Valeant Pharma Says Ryan Weldon To Leave After Skin Care Rights' Sale To Nestle

RELATED NEWS
Trade VRX now with 

Canadian drug maker Valeant Pharmaceuticals International, Inc. (VRX: Quote,VRX.TO: Quote) late Friday announced that Executive Vice President and Company Group Chairman Ryan Weldon will leave the firm following the divestiture of its skin care rights to Swiss foods giant Nestle SA (NSRGY.PK,NSTR.L).

It was on May 28 that Valeant agreed to sell its skin care rights, which includes rights of Restylane, Perlane, Emervel, Sculptra, and Dysport, to Nestle for $1.4 billion cash.

Nestle expects to operate the acquired assets through Swiss dermatology pharmaceuticals company Galderma, the acquisition of which will be completed by Nestle in July. Galderma was a 50/50 joint venture between French cosmetics maker L'Oreal Co. (LRLCY.PK) and Nestlé.

Valeant Michael Pearson, chairman and chief executive officer, said, "As a clear testament to the performance of Valeant's aesthetic commercial team, Galderma is in discussions with the injectable team to discuss long-term opportunities. Although his leadership will be missed, the company has created and developed a strong management team and I am confident Ryan will assist us successfully through this transition period."

Click here to receive FREE breaking news email alerts for Valeant Pharmaceuticals International and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Initial jobless claims in the U.S. fell by slightly more than expected in the week ended August 16th, according to a report released by the Labor Department on Thursday. The Labor Department said jobless claims dropped to 298,000, a decrease of 14,000 from the previous week's revised level of 312,000. After ending the previous session mostly higher, stocks may see some further upside in early trading on Thursday. The major index futures are currently pointing to a higher open for the markets, with the Dow futures up by 36 points. U.K. retail sales growth eased in July as auto fuel turnover declined markedly from June, official data showed Thursday. The public sector finance figures were also weaker than expected in July despite economic rebound. Including auto fuel, retail sales volume grew 0.1 percent in July from a month ago, slower than the revised 0.2 percent increase in June, the Office for National Statistics said.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.